Citric acid calcium malate drug tablet

A technology of calcium malate and tablet, applied in the dosage form of high-efficiency calcium supplement, calcium citrate malate pharmaceutical tablet dosage form field, can solve the problem of low calcium gluconate content, unfavorable physical health, and calcium citrate solubility. lower problem

Active Publication Date: 2014-04-09
HAINAN UNIPUL PHARMA
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Organic calcium nutrition fortifiers have good solubility, little irritation to the gastrointestinal tract, and high hygiene and safety, but they generally have disadvantages such as low calcium content and varying degrees of toxic and side effects (Yang Zhen et al., 2006)
For example, the lactic acid root contained in calcium lactate is easy to bring fatigue to the human body (Zhou Jun, 2002), the calcium content of calcium gluconate is low, the intestinal calcium absorption rate is not high, and it is not suitable for diabetic patients (Lv Weiqing, 2000); The solubility of calcium citrate is very low, so it is not suitable for liquid food or solid food that needs to be prepared, and it has been found through research that calcium citrate will promote the absorption of metal ions and aluminum ions by the human body, which is not conducive to health (Lin Xufang, 2005) ;Calcium acetate is a better inhibitor of phosphorus in hyperphosphatemia, but it is rarely used as a calcium supplement, which may be related to its tendency to cause hypercalcemia and calcification of some soft tissues, so it has not been certified by the US FDA. Studies have shown that calcium acetate can seriously inhibit the absorption of trace element zinc in the small intestine (Hwang S J. Lai Y H, 1992), so it cannot be taken for a long time

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Citric acid calcium malate drug tablet
  • Citric acid calcium malate drug tablet
  • Citric acid calcium malate drug tablet

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0040] 1. Synthesis of raw materials and preparation process research

[0041] Screening of synthesis process and properties of raw materials

[0042] Process 1-1: preparing calcium citrate malate with a molar ratio of calcium:citric acid:malic acid of 6:2:3. Dissolve 384.2 grams of citric acid and 402.3 grams of malic acid in 2 liters of water, and heat the solution of citric acid / malic acid to 55°C (salt-forming reaction temperature) while stirring. Separately, 600.6 grams of calcium carbonate was added to 1.2 liters of water with stirring to form a slurry. Remove the heat source from the citric / malic acid solution, and slowly add the calcium carbonate slurry, with stirring. The rate of addition should be controlled to control the evolution of carbon dioxide from the reaction. An additional water volume of about 0.4 liters is added at the end. The reaction mixture was then stirred for about 1 to 1.5 hours. The reaction was essentially complete and the pH of the solution...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
survival rateaaaaaaaaaa
Login to view more

Abstract

The invention belongs to the technical field of a drug preparation, relates to a dosage form of an efficient calcium supplement agent, and particularly relates to a dosage form of a citric acid calcium malate drug tablet. According to the technical scheme, a citric acid calcium malate product which is more popular with people in need is provided in the way of improving he citric acid calcium malate product. The citric acid calcium malate drug tablet is characterized by only containing citric acid calcium malate drug instead of other ingredients; and concretely the citric acid calcium malate drug is made from powder in a direct tabletting manner. The citric acid calcium malate drug tablet has the advantages of high solubility, high absorption utilization, is safe and nontoxic, does not affect iron absorption of a human body, and does not destroy gastrointestinal acid-base balance.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical dosage forms, and relates to a dosage form of a high-efficiency calcium supplement, in particular to a pharmaceutical tablet dosage form of calcium citrate malate. Background technique [0002] Calcium citrate malate, also known as calcium citrate malate, calcium fruit acid, Calcium Citrate Malate, CCM, is a highly efficient calcium supplement. [0003] 1. The development and research status of calcium nutrition fortifiers [0004] Regarding the development and research status of calcium nutrition fortifiers (excerpted from Liu Hongling, 2007), there are more than 40 kinds of calcium nutrition fortifiers allowed to be used internationally. Nutrient enhancers include: active calcium, calcium carbonate, calcium aspartate, calcium acetate, calcium glycinate, natural bone meal, calcium citrate, calcium hydrogen phosphate, calcium lactate, calcium threonate, calcium gluconate 11 kinds, and Pra...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/20A61K31/194A61P3/02
Inventor 夏文晖郑尚鸿林明海
Owner HAINAN UNIPUL PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products